Flavitan


Indications and Reactions:

Role Indications Reactions
Secondary
Upper Respiratory Tract Inflammation 57.1%
Drug Use For Unknown Indication 28.6%
Neutropenia 14.3%
Interstitial Lung Disease 50.0%
Stomatitis 50.0%
Concomitant
Prophylaxis 26.0%
Drug Use For Unknown Indication 8.6%
Stomatitis 8.3%
Rheumatoid Arthritis 7.0%
Hypertension 5.9%
Product Used For Unknown Indication 5.1%
Ovarian Cancer Recurrent 5.0%
Idiopathic Thrombocytopenic Purpura 4.7%
Bronchitis 3.3%
Hepatitis C 3.1%
Insomnia 3.0%
Ankylosing Spondylitis 2.8%
Asthma 2.5%
Osteoporosis 2.5%
Gastritis 2.3%
Metastases To Lung 2.2%
Chronic Hepatitis C 2.0%
Constipation 2.0%
Dermatitis Atopic 1.9%
Lung Adenocarcinoma Recurrent 1.9%
Interstitial Lung Disease 13.1%
Rhabdomyolysis 8.3%
Seborrhoeic Dermatitis 8.3%
Stomatitis 8.3%
Rash 6.0%
Sepsis 6.0%
Platelet Count Decreased 4.8%
Pyrexia 4.8%
Staphylococcal Infection 4.8%
Ventricular Tachycardia 4.8%
White Blood Cell Count Decreased 4.8%
Cachexia 3.6%
Diabetic Nephropathy 3.6%
Tooth Extraction 3.6%
Weight Increased 3.6%
Blood Creatine Phosphokinase Increased 2.4%
Cerebral Haemorrhage 2.4%
Cerebral Infarction 2.4%
Delirium 2.4%
Disseminated Intravascular Coagulation 2.4%

Drug Data